Recurrent Grade IV Glioma
1 clinical trials · Condition
◉ Watch Recurrent Grade IV Glioma
| Record | Firm | Date |
|---|---|---|
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas (NCT01172964) | City of Hope Medical Center | 2010-08-01 |
Track Recurrent Grade IV Glioma automatically
Every clearance here is in the API, with alerts when new ones post.